LIXT
Lixte Biotechnology Holdings Inc
NASDAQ: LIXT · HEALTHCARE · BIOTECHNOLOGY
$3.50
+0.00% today
Updated 2026-04-30
Market cap
$44.15M
P/E ratio
—
P/S ratio
20.35x
EPS (TTM)
$-1.26
Dividend yield
—
52W range
$1 – $6
Volume
0.0M
Lixte Biotechnology Holdings Inc (LIXT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-443451.00 | $-702868.00 | $-597689.00 | $-638440.00 | $-936394.00 | $-1.36M | $-1.21M | $-1.18M | $-1.64M | $-2.18M | $-1.68M | $-1.41M | $-1.51M | $-1.67M | $-2.13M | $-4.14M | $-4.61M | $-4.29M | $-3.16M | $-3.07M |
| Capital expenditures | $498.00 | $272.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.00 | $5.00 | $3.00 | $5.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $890444.00 | $571048.00 | $745980.00 | $160712.00 | $204898.00 | $1.02M | $119250.00 | $946173.00 | $549697.00 | $287159.00 | $70695.00 | $785612.00 | $748655.00 | $1.25M | $2.60M | $1.55M | $773203.00 | $418422.00 | $1.56M |
| Free cash flow | $-443949.00 | $-703140.00 | $-597689.00 | $-638440.00 | $-936394.00 | $-1.36M | $-1.21M | $-1.18M | $-1.64M | $-2.18M | $-1.68M | $-1.41M | $-1.51M | $-1.67M | $-2.13M | $-4.14M | $-4.61M | $-4.29M | $-3.16M | $-3.07M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $100000.00 | — | — | — | — | $2000.00 | $2000.00 | $2000.00 | — | — | — | — | — | — | — | — | $69.07M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |